Medical knowledge of glioblastoma multiforme (GBM), the deadliest form of brain cancer, has grown exponentially, but has not resulted in marked improvements in treatment for patients. Addressing this is GBM AGILE (GBM Adaptive Global Innovative Learning Environment), a global medical and scientific coalition that is the first platform trial for…...
(clockwise) NFCR President Dr. Sujuan Ba, ECI Founder Mr. Andrew Forrest and PhIRDA Executive President Mr. Song Ruilin In recent months, the National Foundation for Cancer Research (NFCR) has signed memorandums of understanding with two major foreign institutions, the China Pharmaceutical Innovation and Research Development Association (PhIRDA) and the Australia-based…...
The National Foundation for Cancer Research’s (NFCR) presence is considerable at the 109th annual meeting of the American Association for Cancer Research (AACR), which kicks off tomorrow in Chicago and runs through the following four days. One of the most widely anticipated regular gatherings of cancer scientists in the United…...
In recognition of Esophageal Cancer Awareness Month, this National Foundation for Cancer Research post offers a look at a significant diagnostic advancement for a risk factor associated with the terrible disease. A new test for Barrett’s esophagus, a precancerous forerunner of the much deadlier esophageal adenocarcinoma, is in clinical trials…...
Cancer can often feel like a disease of mysterious origin. There are difficult to pronounce words, complex statistics and evolving theories involved in the explanation of the development of cancer. Its nefariousness and criticality can create a fear-associated mental distancing or even an attitude of fatalism. Together, this can allow…...
Free Cancer Screening Guidelines
National Foundation for Cancer Research(NFCR) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #: 04-2531031
5515 Security Lane, Suite 1105 Rockville, MD 20852
